53
Participants
Start Date
March 22, 2019
Primary Completion Date
December 15, 2022
Study Completion Date
March 22, 2023
Neurocytotron
Neurocytotron utilizes a combination of instantaneous magnetic field and low-spectrum radiofrequency waves for therapeutic purpose. Its working principle is based on the theory of magnetic resonance.
Placebo
Same treatment procedures without being actually exposed to electromagnetic waves and magnetic field
NeuroCytonix México, Monterrey
Collaborators (1)
KCRN Research, LLC
INDUSTRY
Neurocytonix, Inc.
INDUSTRY